In a separate TMA cohort containing tumor tissues from CCA patients, IGF1R expression levels were evaluated and patients were stratified into IGF1RHigh and IGF1RLow groups based on the median IHC score. The gene discussed is IGF1R; the disease is cholangiocarcinoma.